In recent years, there has been increasing literature on the role of GDF-15 as a prognostic biomarker in the acute care setting, including sepsis, renal disease, chronic obstructive airway disease, COVID-19, and myocardial infarction [23, 24, 41, 42]. Here, GDF15 is linked to kidney disorder.